Taken together, MMPs (mainly MMP-9) and TIMP-1 may contribute to progressive loss of lung function and increased cellular matrix fibrosis of the airway wall in chronic asthmatics who demonstrated a poor response to anti-asthma treatments. Here, MMP9 is linked to asthma.